The largest database of trusted experimental protocols

Anti human cd45 pe

Manufactured by Thermo Fisher Scientific
Sourced in France, United States

The Anti-Human CD45 PE is a lab equipment product used to identify and quantify CD45-positive cells in biological samples. It is a fluorochrome-conjugated monoclonal antibody that specifically binds to the CD45 antigen expressed on the surface of various hematopoietic cells.

Automatically generated - may contain errors

2 protocols using anti human cd45 pe

1

Immunostaining and Imaging of Captured Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The captured cells were fixed and treated inside the device. 4% paraformaldehyde (PFA) diluted in PBS at 10 μl/min for 15 min was injected from inlet 1 to outlet 2, followed by PBS rinsing at 50 μl/min for 6 min. Similarly, 0.2% Triton X-100 in PBS was injected into the device at 10 μl/min for 10 min for permeabilization and 300 μl 1% BSA in PBS was introduced at 10 μl/min for 30 min to block out non-specific bindings. Afterwards, cells were stained with dye solutions (passing from inlet 1 to outlet 1). First, 600 μl immunostaining solution, containing 5 μg/ml Anti-Pan-cytokeratin (AE1/AE3) Alexa Fluor 488- (1:100 diluted in PBS; eBioscience SAS) and Anti-Human CD45 PE (1:20 diluted in PBS, eBioscience SAS, France), was injected at 10 μl/min for 1 h to stain tumor cells and WBCs, respectively. Then, the nucleus were stained by 4′,6-diamidino-2-phenylindole (DAPI,100 nM, Life Technologies) at 10 μl/min for 10 min. Finally, the device was rinsed by 300 µl PBS for 6 min and fluorescence images were obtained with an inverted optical microscope (Zeiss, Axiovert 200) equipped with a digital CCD camera (Evolution QEI).
+ Open protocol
+ Expand
2

Single-Cell CTC Analysis in NSCLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples from stage IV NSCLC patients and healthy donors were obtained with informed consent in accordance with the approved procedures under the institutional review board (IRB) guidelines. The project was approved by the Singhealth Centralised Institutional Review Board (CIRB).
Analysis of the primary tumor was performed as part of the routine procedure during patient recruitment. Sample workflow for single cell capture is illustrated in supplementary Fig. 5 with total processing time of 7.5 hours. Blood samples of 7.5 ml were extracted from each patient if possible. Primary CTC enrichment was carried out via the ClearCell FX system (Clearbridge Biomedics, Singapore) at the Singapore General Hospital. The mixed cell population was then stained with Anti-Human CD45 PE (eBioscience, Inc., CA, USA) and further depleted of WBCs using our device and recovered as single cells in PCR tubes. The additional primer pair for L858R is as follows.
Forward: 5′- CTAACGTTCGCCAGCCATAAGTCC-3′
Reverse: 5′- GCTGCGAGCTCACCCAGAATGTCTGG-3′
Amplicons were sent for direct sequencing after purification. Results were single blinded and compiled after analyzing the direct sequencing results of all isolated single cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!